Inflammatory control is essential to diminish injury and make renal injury treatment simpler. Proposed therapeutics have primarily targeted pro-inflammatory variables. Juniperus oxycedrus was frequently used to treat a variety of infectious disorders, hyperglycemia, obesity, TB, bronchitis, inflammation, and pneumonia. Juniperus oxycedrus twigs and leaves were defatted with n-hexane using Soxhlet apparatus then the residue of plant material dried and re-extracted sequentially by two different solvents Ethylacetate and methanol. The pro-inflammatory markers IL-1 and iNOS, as well as the potential kidney biomarker KIM-1, TNF-α, and transcription factor NF-KB were measured using the RealTime Quantitative qPCR method. The results showed that Juniperus oxycedrus Ethylacetate and methanol extracts inhibit IL-1β, iNOS, TNF-α, NF-KB, and KIM-1induced by LPS significantly (p<0.05) in 200 and 400mg/kg/day of both crude extract. In conclusion the data suggest that ethylacetate and methanol crude extracts have strong anti-inflammatory and reno-protective effects in acute kidney injury induced by LPS in a mouse model, which were demonstrated by the hampering effect on KIM-1, IL1, NF-KB, TNF-α, and iNOS mRNA expression levels via NF-KB signaling pathways inhibition.